Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00140036
Status:
COMPLETED
Last Update Posted:
2008-03-03
First Post:
2005-08-29
Brief Title:
Pharmacogenomics Blood Sampling Protocol For IrinotecanFluorouracilLeucovorinCPT-11FULV
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Pharmacogenomics Blood Sampling Protocol For IrinotecanFluorouracilLeucovorinCPT-11FULV
Status:
COMPLETED
Status Verified Date:
2008-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This protocol describes procedures for the collection of blood samples for the intent of determining genetic contribution to the safety and efficacy of CPTFULV
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| A5961020 | None | None | None |